Takeda Pharmaceutical Company Limited announced appointment of senior leadership, effective October 1, 2014:. The details are: Mwana Lugogo as Global Compliance Officer. The company appointed Haruhiko Hirate as Corporate Officer, Corporate Communications & Public Affairs Officer, Senior Vice President, Corporate Communications Department from the previous position of Corporate Officer, Senior Vice President, Head of North Asia.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,130 JPY | -0.19% | +0.02% | +1.87% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 41.81B | |
+31.89% | 694B | |
+29.22% | 593B | |
-1.63% | 371B | |
+19.72% | 331B | |
+6.64% | 290B | |
+14.13% | 239B | |
-2.94% | 209B | |
+10.00% | 209B | |
+8.13% | 169B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Executive Appointments, Effective from October 1, 2014